Activated Neutrophils Exert Antitumor Activity Against Human Melanoma Cells: Reactive Oxygen Species-Induced Mechanisms and Their Modulation by Granulocyte-Macrophage-Colony-Stimulating Factor [2]

Journal of Investigative Dermatology

Volumn 121, Issue 4, 2003, Pages 936-938

  Dissemond, Joachim ^a   Weimann, Tatjana K ^a   Schneider, Lars A ^b   Schneeberger, Achim ^c,d   Scharffetter Kochanck, Karin ^b   Goos, Manfred ^a   Wagner, Stephan N ^a  

^a University School of Medicine   (Germany)

^b UNIVERSITY OF ULM MEDICAL SCHOOL   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; DNA FRAGMENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROGEN PEROXIDE; HYDROXYL RADICAL; NITRIC OXIDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SUPEROXIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LETTER; LEUKOCYTE ACTIVATION; LYMPHOCYTE CULTURE; LYMPHOCYTIC INFILTRATION; MELANOMA; MODULATION; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR CELL DESTRUCTION;

EID: 0141991112     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12475.x     Document Type: Letter

References (20)

1. Armstrong CA, Botella R, Galloway TH, Murray N, Kramp JM, Song IS, Ansel JC: Anti-tumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res 56:2191-2198, 1996
2. Cavallo F, Giovarelli M, Gulino A, Vacca A, Stoppac-Ciaro A, Modesti A, Forni G: Role of neutrophils and CD4+ T lymphocytes in the primary and memory responce to nonimmunogenic marine mammary adenocarcinoma made imminugenic by IL-2. J Immunol 149:3627-3636, 1992
3. Clark RA, Nauseef WM: Superoxide formation: Kinetic assay. Preparation and functional analysis of human nonlymphoid cells.. In: Coligan JE, Kruisbeek AM, Margulis DH, Shevach EM, Strober W (eds). Current Protocols in Immunology. New York: Wiley; 1998
4. Colombo MP, Modesti A, Parmiani G, Forni G: Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res 52:4853-4856, 1992
5. Elbim C, Bailly S, Chollet-Martin S, Hakim J, Gougerot-Pocidalo MA: Differntial priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides. Infect Immun 62:2195-2201, 1994
6. Finkel T, Holbrook N: Oxidants, oxidative stress and the biology of ageing. Nature 408:239-247, 2000
7. Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM: Treatment of established renal cancer by tumor cell engineered to secrete interleukin-4. Science 254:713-716, 1991
8. Gougerot-Pocidalo MA, el Benna J, Elbim C, Chollet-Martin S, Dang MC: Regulation of human neutrophil oxidative burst by pro- and anti-inflammatory cytokines. J Soc Biol 196:37-46, 2002
9. Halliwell B: A super way to kill cancer cells? Nat Med 6:1105-1106, 2000
10. Herrera B, Alvarez AM, Sanchez A, Fernande M, Roncero C, Benito M, Fabregat I: Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor in fetal hepatocytes. FASEB J 15:741-751, 2001
11. Hock H, Dorsch M, Kunzendorf U, Qin Z, Diamantenstein T, Blankenstein T: Mcchanisms of rejection induced by tumor cell-targeted gene transfer of interleukin-2, interleukin-4, interleukin-7, tumor necrosis factor, or interferon gamma. Proc Natl Acad Sci USA 90:2774-2778, 1993
12. Karnat JP, Devasagayam TP: Oxidative damage to mitochondria in normal and cancer tissues, and its modulation. Toxicology 155:73-82, 2000
13. Kannan K, Jain SK: Oxidative stress and apoptosis. Pathophysiology 7:153-163, 2000
14. Mastrangelo MJ, Maguire HC Jr, Eisenlohr LC, et al: Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma. Cancer Gene Ther 6:409-422, 1999
15. Musiani P, Allione A, Modica A. et al: Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, 1L-10, IFN-alpha, IFN-gamma, and TNF-alpha. Lab Invest 74:146-157, 1996
16. Noffz G, Qin Z, Kopf M, Blankenstein T: Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors. J Immunol 160:345-350, 1998
17. Pardoll DM: Does the immune system see tumors as foreign or self? Annu Rev Immunol 21:807-839, 2003
18. Soiffer R, Lynch T, Mihm M, et al: Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent anti-tumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci USA 95:13141-13146, 1998
19. van Asbeck BS, Marx JJM, Struyvenberg A, van Kats JH, Verhoef J: Deferoxamine enhances phagocytic function of human polymorphonuclear leukocytes. Blood 63:714-720, 1984
20. Walzog B, Jeblonski F, Zakrzewicz A, Gaehtgens P: β2 Integrins (CD11/CD18) promote apoptosis of human neutrophils. FASEB J 11:1177-1186, 1997